KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb
Produktbild: Fibrin formation and Fibrinolysis
Band 4

Fibrin formation and Fibrinolysis April, 2–3, 1985, London, England

Aus der Reihe Fibrinogen. Proceedings/ Workshop on Fibrinogen

179,95 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

01.03.1986

Abbildungen

Num. figs.

Herausgeber

D. A. Lane

Verlag

De Gruyter

Seitenzahl

396

Maße (L/B/H)

24,6/17,5/2,8 cm

Gewicht

899 g

Auflage

Reprint 2019

Sprache

Deutsch

ISBN

978-3-11-010597-1

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

01.03.1986

Abbildungen

Num. figs.

Herausgeber

D. A. Lane

Verlag

De Gruyter

Seitenzahl

396

Maße (L/B/H)

24,6/17,5/2,8 cm

Gewicht

899 g

Auflage

Reprint 2019

Sprache

Deutsch

ISBN

978-3-11-010597-1

Herstelleradresse

Walter de Gruyter
Genthiner Straße 13
10785 Berlin
DE

Email: productsafety@degruyterbrill.com

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben und erhalten Sie dafür eine Thalia Geschenkkarte.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Weitere Artikel finden Sie in
  • Produktbild: Fibrin formation and Fibrinolysis
  • Frontmatter -- Preface -- Contributors -- Contents -- I. Synthesis And Assembly -- A scheme for the intracellular assembly of human fibrinogen -- Evidence that platelet and plasma fibrinogen have the same A-alpha chain gene product -- Fibrinopeptide A and the phosphorylation of fibrinogen -- II. Structure and Function -- Size and shape of the fibrinogen molecule: crystalline forms of native and modified human fibrinogen -- The C-terminal polymerisation domain of fibrinogen -- ?- Chain Crosslinking Of Fibrin At Dd-Trans Contact -- Soluble fibrin contains fibrin polymers of different molecular weight. Ultracentrifugation studies at 37°C -- Relationship of final thickness of fibrin fibers to maximal rate of assembly and to fibrinopeptide B release -- III. Congenital Variants -- Fibrinogen New York 1: The structural, functional, and genetic defects and an hypothesis of the role of fibrin in the regulation of coagulation and fibrinolysis -- Fibrinogen Pontoise - a genetically abnormal fibrinogen with defective fibrin polymerisation but normal fibrinopeptide release -- Fibrinogen Milano I: Abnormal fibrin polymerization related to a carboxy-terrainal defect of the ?-chain (?-330 Asp Val) -- Fibrinogen "Bergamo I" (?? 16 Arg - Cys): Alternative methods for structure elucidation -- Screening small plasma samples by HPLC for abnormalities of fibrinopeptide release -- Iv. Fibrin(ogen) And Fibrinolysis -- On the role of fibrin in the fibrinolytic system -- Isolation and characterisation of plasmic degradation products of fibrinogen by high-performance liquid chromatography -- The acceleration of tissue-type plasminogen activator (t-PA)-mediated activation of plasminogen by fibrinogen cyanogen bromide fragments is species specific -- Role of fibrin polymerization in fibrinolysis: Comparison between polymerisable and unpolymerisable fibrins in the potentiating effect of plasminogen activation by tissue-type plasminogen activator (tpA) -- Role of fibrin and its degradation products in the activation of plasminogen by streptokinase and urokinase -- V. Interactions With Cells -- The role of fibrinogen in platelet aggregation -- Platelet-associated fibrinogen: Conformational change of fibrinogen induced by its adsorption to platelet-surface -- Migration of cultured endothelial cells in response to fibrinogen -- Characteristics of the interactions of fibrinogen and soluble fibrin with cultured endothelial cells -- Mechanism of fibrin-induced disorganisation of cultured human endothelial cells -- The fibrinogen: red cell interaction and its influence on blood rheology -- Haemorheologic effects of plasmin and thrombininduced fibrinogen derivatives: An in vitro study -- Binding of human fibrinogen to streptococci and its role in streptococcal pathogenicity -- VI. Assays To Fibrin(ogen) Fragments And Their Use -- Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic hexapeptide representing the amino-terminus of the alpha-chain of fibrin -- A new enzyme immunoassay of fibrin(ogen) degradation products in plasma using a monoclonal antibody -- Fibrin(ogen) degradation products. Determination using a monoclonal anti D neo antibody. Advantages in clinical investigation -- A monoclonal antibody, specific for human fibrinogen and fibrinopeptide A-containing fragments. Its application in an enzyme-immunoassay for fibrinogen degradation products, suitable for use in plasma -- A monoclonal antibody against the CNBr-peptide F-CB3 of the A?-chain of human fibrinogen -- Clinical aspects of fibrin formation and fibrinolysis measured with monoclonal antibodies against D-dimer -- Fibrinogen derivatives in acute stroke -- VII. Fibrin(ogen) And Disease Pathology -- Triggering of the extrinsic blood coagulation system -- Extravascular fibrin formation and fibrinolysis in a model of inflammation accompanying cellular hypersensitivity -- Extra-vascular fibrin deposition in cellular hypersensitivity - the role of T lymphocyte-macrop